Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Congenital disorders of platelet function.

¹Department of Medicine, Temple University School of Medicine, Philadelphia, Pennsylvania.

Hematology/Oncology Clinics of North America

|February 1, 1990

Summary

Congenital platelet function disorders cause variable bleeding. While platelet transfusions are standard, desmopressin (DDAVP) shows promise for some patients, though its efficacy needs further study.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Defective acid hydrolase secretion in RUNX1 haplodeficiency: Evidence for a global platelet secretory defect.

Haemophilia : the official journal of the World Federation of Hemophilia·2017

Same author

Dysregulation of PLDN (pallidin) is a mechanism for platelet dense granule deficiency in RUNX1 haplodeficiency.

Journal of thrombosis and haemostasis : JTH·2017

Same author

Recommendations for the Standardization of Light Transmission Aggregometry: A Consensus of the Working Party from the Platelet Physiology Subcommittee of SSC/ISTH.

Journal of thrombosis and haemostasis : JTH·2013

Same author

Transfer of disability care of leprosy to the affected persons and the community members.

Indian journal of leprosy·2011

Same author

Response of thickened nerve trunks and skin lesions of leprosy patients to MDT.

Indian journal of leprosy·2011

Same author

Mechanism of platelet factor 4 (PF4) deficiency with RUNX1 haplodeficiency: RUNX1 is a transcriptional regulator of PF4.

Journal of thrombosis and haemostasis : JTH·2010

Area of Science:

Hematology
Molecular Biology
Genetics

Background:

Congenital platelet function disorders present with mucocutaneous bleeding of varying severity.
These defects arise from diverse mechanisms, impacting platelet interactions, secretion, or coagulation protein binding.

Purpose of the Study:

To classify congenital platelet function disorders.
To review current management strategies and explore novel therapeutic options.

Main Methods:

Literature review of congenital platelet disorders.
Analysis of current treatment modalities including platelet transfusions and DDAVP.

Main Results:

Most congenital platelet dysfunctions, excluding von Willebrand disease (vWD), are platelet secretion defects.
Platelet transfusions are the primary treatment for bleeding episodes and surgical procedures.
Intravenous desmopressin (DDAVP) may shorten bleeding time in some patients, but specific responders and clinical efficacy require further investigation.

Conclusions:

Congenital platelet function disorders are heterogeneous, with platelet secretion defects being most common.
While platelet transfusions remain crucial, DDAVP presents a potential alternative for specific patient groups.
Further research is needed to establish DDAVP's role and identify patient subgroups who benefit most.

Related Experiment Videos